ID   N202.1E
AC   CVCL_RW57
SY   N202/1E
DR   Wikidata; Q54907329
RX   PubMed=11696586;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB N#202 transgenic for HER-2/neu.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
RX   PubMed=11696586; DOI=10.1084/jem.194.9.1195; PMCID=PMC2195980;
RA   Nanni P., Nicoletti G., De Giovanni C., Landuzzi L., Di Carlo E.,
RA   Cavallo F., Pupa S.M., Rossi I., Colombo M.P., Ricci C., Astolfi A.,
RA   Musiani P., Forni G., Lollini P.-L.;
RT   "Combined allogeneic tumor cell vaccination and systemic interleukin
RT   12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.";
RL   J. Exp. Med. 194:1195-1205(2001).
//